Literature DB >> 16081631

A positive feedback loop that regulates cyclooxygenase-2 expression and prostaglandin F2alpha synthesis via the F-series-prostanoid receptor and extracellular signal-regulated kinase 1/2 signaling pathway.

Henry N Jabbour1, Kurt J Sales, Sheila C Boddy, Richard A Anderson, Alistair R W Williams.   

Abstract

Cyclooxygenase (COX) enzymes catalyze the biosynthesis of eicosanoids, including prostaglandin (PG) F2alpha. PGF2alpha exerts its autocrine/paracrine function by coupling to its G protein-coupled receptor [F-series-prostanoid (FP) receptor] to initiate cell signaling and target gene transcription. In the present study, we found elevated expression of COX-2 and FP receptor colocalized together within the neoplastic epithelial cells of endometrial adenocarcinomas. We investigated a role for PGF2alpha-FP receptor interaction in modulating COX-2 expression and PGF2alpha biosynthesis using an endometrial adenocarcinoma cell line stably transfected with the FP receptor cDNA (FPS cells). PGF2alpha-FP receptor activation rapidly induced COX-2 promoter, mRNA, and protein expression in FPS cells. These effects of PGF2alpha on the expression of COX-2 could be abolished by treatment of FPS cells with an FP receptor antagonist (AL8810) and chemical inhibitor of ERK1/2 kinase (PD98059), or by inactivation of ERK1/2 signaling with dominant-negative mutant isoforms of Ras or ERK1/2 kinase. We further confirmed that elevated COX-2 protein in FPS cells could biosynthesize PGF2alpha de novo to promote a positive feedback loop to facilitate endometrial tumorigenesis. Finally, we have shown that PGF2alpha could potentiate tumorigenesis in endometrial adenocarcinoma explants by inducing the expression of COX-2 mRNA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16081631     DOI: 10.1210/en.2005-0804

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  20 in total

Review 1.  Cyclooxygenases and lipoxygenases in cancer.

Authors:  Claus Schneider; Ambra Pozzi
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

2.  Anandamide-derived prostamide F2α negatively regulates adipogenesis.

Authors:  Cristoforo Silvestri; Andrea Martella; Neil J Poloso; Fabiana Piscitelli; Raffaele Capasso; Angelo Izzo; David F Woodward; Vincenzo Di Marzo
Journal:  J Biol Chem       Date:  2013-06-25       Impact factor: 5.157

Review 3.  Inhibitors of type 5 17β-hydroxysteroid dehydrogenase (AKR1C3): overview and structural insights.

Authors:  Michael C Byrns; Yi Jin; Trevor M Penning
Journal:  J Steroid Biochem Mol Biol       Date:  2010-11-16       Impact factor: 4.292

4.  Interleukin-11 in endometrial adenocarcinoma is regulated by prostaglandin F2alpha-F-prostanoid receptor interaction via the calcium-calcineurin-nuclear factor of activated T cells pathway and negatively regulated by the regulator of calcineurin-1.

Authors:  Kurt J Sales; Vivien Grant; Ian H Cook; David Maldonado-Pérez; Richard A Anderson; Alistair R W Williams; Henry N Jabbour
Journal:  Am J Pathol       Date:  2009-12-11       Impact factor: 4.307

5.  PGF2α-F-prostanoid receptor signalling via ADAMTS1 modulates epithelial cell invasion and endothelial cell function in endometrial cancer.

Authors:  Margaret C Keightley; Kurt J Sales; Henry N Jabbour
Journal:  BMC Cancer       Date:  2010-09-14       Impact factor: 4.430

6.  F-prostanoid receptor alters adhesion, morphology and migration of endometrial adenocarcinoma cells.

Authors:  K J Sales; S C Boddy; H N Jabbour
Journal:  Oncogene       Date:  2007-10-29       Impact factor: 9.867

7.  CREB mediates prostaglandin F2alpha-induced MUC5AC overexpression.

Authors:  Wen-Cheng Chung; Seung-Hee Ryu; Hongxia Sun; Darryl C Zeldin; Ja Seok Koo
Journal:  J Immunol       Date:  2009-02-15       Impact factor: 5.422

8.  Prostaglandin F2alpha-F-prostanoid receptor signaling promotes neutrophil chemotaxis via chemokine (C-X-C motif) ligand 1 in endometrial adenocarcinoma.

Authors:  Alison E Wallace; Kurt J Sales; Roberto D Catalano; Richard A Anderson; Alistair R W Williams; Martin R Wilson; Jurgen Schwarze; Hongwei Wang; Adriano G Rossi; Henry N Jabbour
Journal:  Cancer Res       Date:  2009-06-23       Impact factor: 12.701

9.  Seminal plasma and prostaglandin E2 up-regulate fibroblast growth factor 2 expression in endometrial adenocarcinoma cells via E-series prostanoid-2 receptor-mediated transactivation of the epidermal growth factor receptor and extracellular signal-regulated kinase pathway.

Authors:  S Battersby; K J Sales; A R Williams; R A Anderson; S Gardner; H N Jabbour
Journal:  Hum Reprod       Date:  2006-08-12       Impact factor: 6.918

10.  Expression of oestrogen receptors, ERalpha, ERbeta, and ERbeta variants, in endometrial cancers and evidence that prostaglandin F may play a role in regulating expression of ERalpha.

Authors:  Frances Collins; Sheila MacPherson; Pamela Brown; Vincent Bombail; Alistair R W Williams; Richard A Anderson; Henry N Jabbour; Philippa T K Saunders
Journal:  BMC Cancer       Date:  2009-09-16       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.